Press "Enter" to skip to content

Vertex Pharmaceuticals (VRTX): Q3 2019 Earnings Snapshot

— Vertex Pharmaceuticals (NASDAQ: VRTX) reported third-quarter 2019 earnings of $1.23 per share, vs. $1.15 per share expected

— Total revenue grew 21% to $949.8 million, vs $950.9 million expected.

— Reiterated FY19 product revenues guidance of $3.70 – 3.75 billion. Non-GAAP effective tax rate outlook was also unchanged at 21-22%.

— VRTX shares were down 0.14% immediately following the announcement.

Vertex Pharmaceuticals Q3 2019 Earnings Infographic

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Top
%d bloggers like this: